Israeli researchers have made a significant breakthrough in Alzheimer’s treatment, demonstrating the potential of Deep Brain Stimulation (DBS) to prevent memory deterioration in animal models. This innovative approach, known for its use in treating Parkinson’s disease, involves the delivery of electrical impulses to specific brain areas to modulate neural activity. The study’s success opens new avenues for Alzheimer’s research, offering hope for interventions that could halt or reverse the progression of this devastating disease. This article explores the methodology, findings, and implications of this pioneering research, including the invasive nature of DBS and what it means for future therapeutic strategies.
(Note: Bibliography, videos, and About Us are found at the end of this article)
The Study’s Innovation
Alzheimer’s disease, characterized by progressive memory loss and cognitive decline, has long eluded effective treatment. The Israeli research team’s application of deep brain stimulation (DBS) represents a novel approach to Alzheimer’s, targeting the brain’s electrical signaling to influence disease progression. By focusing on specific neural circuits involved in memory and cognition, the researchers aimed to stabilize or improve these functions in animals predisposed to Alzheimer’s-like symptoms.
Methodology and Findings
The study involved surgically implanting devices that deliver electrical impulses to targeted brain regions in animal models. These devices were programmed to modulate the activity of neural circuits implicated in memory and learning. The animals subjected to DBS showed a remarkable preservation of memory functions compared to those in the control group, indicating the procedure’s potential to counteract the effects of Alzheimer’s.
Significance of the Findings
This research marks a critical step forward in Alzheimer’s treatment, suggesting that DBS could offer a viable strategy for managing and possibly reversing cognitive decline in patients. The ability to modulate brain activity and preserve memory function without relying solely on pharmaceuticals could revolutionize Alzheimer’s care, providing a more targeted and potentially more effective treatment option.
The Invasive Nature of DBS
While the promise of DBS in Alzheimer’s treatment is immense, the technique’s invasive nature warrants discussion. DBS requires surgical intervention to implant electrodes in the brain, a process that carries risks such as infection, bleeding, and other complications. The ethical and practical considerations of applying such an invasive procedure to Alzheimer’s patients, especially in the disease’s early stages, must be thoroughly evaluated.
Potential Implications and Challenges
The application of DBS in Alzheimer’s research opens up new therapeutic possibilities but also introduces challenges. The transition from animal models to human patients involves complex ethical, medical, and technical hurdles. There’s also the matter of determining the optimal timing for intervention, patient selection criteria, and long-term effects of brain stimulation. Moreover, the cost and accessibility of DBS treatment could pose significant barriers to widespread adoption.
Conclusion/Summary:
The Israeli researchers’ breakthrough in using Deep Brain Stimulation to prevent memory deterioration in animal models represents a beacon of hope in the battle against Alzheimer’s disease. This innovative approach could pave the way for developing treatments that not only manage symptoms but also target the disease’s underlying mechanisms. However, the invasive nature of DBS, along with the technical, ethical, and accessibility challenges, highlights the complexity of translating this success into a practical treatment for Alzheimer’s patients. As research progresses, it will be crucial to address these issues, ensuring that the potential benefits of DBS can be realized safely and effectively for those in need.
- All text © 2024 James M. Sims and all images exclusive rights belong to James M. Sims and Midjourney or DALL-E, unless otherwise noted.
References
- Levi, O., Israel, Z., & Eitan, R. (2021). Halting Alzheimer’s cognitive decline using deep brain stimulation in APP/PS1 mice. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-26809-w
- Lozano, A. M., Lipsman, N., Bergman, H., Brown, P., Chabardes, S., Chang, J. W., Matthews, K., McIntyre, C. C., Schlaepfer, T. E., Schulder, M., Temel, Y., Volkmann, J., & Krauss, J. K. (2019). Deep brain stimulation: current challenges and future directions. Nature Reviews Neurology, 15(3), 148–160. https://doi.org/10.1038/s41582-018-0128-2
- Ly, V., Cools, R., & Lehn, H. (2021). Neuromodulation of Cognitive Flexibility and Goal-Directed Behavior in Parkinson’s Disease Models. Frontiers in Neurology, 12. https://doi.org/10.3389/fneur.2021.643142
- Fontaine, D., Deudon, A., Lemaire, J., Razzouk, M., Viau, P., Darcourt, J., & Robert, P. (2013). Symptomatic treatment of memory decline in Alzheimer’s disease by deep brain stimulation: a feasibility study. Journal of Alzheimer’s Disease, 34(1), 315–323. https://doi.org/10.3233/JAD-121715
- Clausen, J. (2011). Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice. European Journal of Neuroscience, 33(7), 1152–1162. https://doi.org/10.1111/j.1460-9568.2010.07591.x
- Fins, J. J., Dorfman, G. S., Pancrazio, J. J., & Krames, E. (2014). Challenges to deep brain stimulation: a pragmatic response to ethical, fiscal, and regulatory concerns. Annals of the New York Academy of Sciences, 1317(1), 103–111. https://doi.org/10.1111/nyas.12407
- Temel, Y., Lewis, S., Hamel, W., Beute, G., Klassen, B., Schuurman, R., Noecker, A., Dogali, M., van Laar, T., & Jahanshahi, A. (2016). Patient selection for deep brain stimulation in Parkinson’s disease. Nature reviews. Neurology, 12(10), 557–566. https://doi.org/10.1038/nrneurol.2016.121
Resources
Deep Brain Stimulation (DBS): Stages of Surgery
Deep Brain Stimulation (DBS) surgery is typically done in three stages. Stage 1 involves placing small screws called bone markers under the scalp while the patient is asleep. MRI and CT-Scans are obtained to assist in DBS placement. Stage 2, which takes place about one week after stage 1, involves the placement of the electrodes. During this procedure, the patient is awake and receives IV pain medication and numbing of the scalp. Being awake is important for the surgeon to determine the proper location for the electrodes. Stage 3 is the placement of the battery and lead extender, which powers the DBS system, under the skin. This stage is done about one week after the DBS electrodes are placed. The battery is placed below the collar bone, and all wires are connected and tested. Following stage 3, the DBS system is left off until the patient follows up with neurology for programming.
Highlights:
0:05 – Stage 1 involves placing small screws called bone markers under the scalp while you’re asleep.
0:26 – Stage 2 involves the placement of the electrodes and is scheduled about one week after the stage 1 surgery.
0:35 – Being awake during stage 2 is vital so that the surgeon can determine the proper location for the electrodes.
1:05 – Stage 3 is the under the skin placement of the battery which powers the DBS system and the lead extender which extends from the head to the chest.
1:15 – Stage 3 is done about one week after the DBS electrodes in the brain are placed.
1:30 – The battery is placed just below the collar bone and all wires are then connected and tested.
1:36 – Following stage 3, the DBS system is left in the off position until you follow up with neurology for programming.
2-Minute Neuroscience: Deep Brain Stimulation
Deep brain stimulation is a neurosurgical approach that uses brain-implanted electrodes to treat neurological and psychiatric conditions. It is primarily used for movement disorders like Parkinson’s disease, but has also been approved for epilepsy and obsessive-compulsive disorder. The procedure involves inserting an electrode into the brain, connected to a pulse generator implanted under the collar bone. By altering neural functioning, deep brain stimulation can alleviate symptoms associated with overactive brain structures. However, it is important to note that deep brain stimulation is a major brain surgery with associated risks. The mechanism of deep brain stimulation and its beneficial effects are still not fully understood, although hypotheses suggest that it may inhibit action potentials, reduce neuronal activity, and disrupt abnormal firing patterns. Further research is needed to gain a clearer understanding of the treatment’s effects on the brain.
Highlights:
0:05 – Deep brain stimulation is a neurosurgical approach that involves the use of brain-implanted electrodes to treat neurological and psychiatric conditions.
0:13 – It is primarily used to treat movement disorders like Parkinson’s disease, but has also been approved for epilepsy and obsessive-compulsive disorder.
0:30 – Deep brain stimulation involves the insertion of an electrode into the brain, connected to a pulse generator implanted under the collar bone.
0:48 – In Parkinson’s disease, the electrode is placed near structures like the subthalamic nucleus to alleviate movement problems.
1:17 – Deep brain stimulation is a major brain surgery with associated risks.
1:22 – The mechanism of deep brain stimulation and its beneficial effects are still not fully understood.
1:26 – Hypotheses suggest that deep brain stimulation may inhibit action potentials, reduce neuronal activity, and disrupt abnormal rhythmic firing.
1:49 – More research is needed to develop a clear understanding of the effects of deep brain stimulation on the brain.
Potential of DBS as a therapeutic strategy in Alzheimer’s disease
Highlights:
0:14 – Clinical trials with promising results on the treatment of DBS.
0:20 – DBS has been used for a long time in Parkinson’s disease to ameliorate tremors.
0:39 – DBS shows neural protection and positive effects in Alzheimer’s disease.
0:52 – Stimulating the brain region called the fornix has shown an increase in hippocampal volume.
1:09 – DBS is the only therapeutic strategy that has shown an increase in hippocampal volume.
1:24 – DBS increases glucose metabolism, which is an early symptom of Alzheimer’s disease.
1:39 – DBS shows promise in subjects at risk of developing Alzheimer’s disease.
1:47 – More research is needed to understand the circuit and cellular mechanisms involved in DBS.
1:55 – Besides a surgical approach, a pharmacological approach may be developed in the future.
About Us - Cielito Lindo Senior Living
Thanks for letting us share this content with you. If you would like to see other articles like this one, they can be found here.
We are Cielito Lindo – a senior care facility in beautiful San Miguel de Allende and we serve as the assisted living and memory care component of Rancho los Labradores, which is a truly incredible one-of-a-kind country club resort-like gated community. Rancho los Labradores consists of individual villas, man made lakes, cobblestone streets, and a rich array of wonderful amenities (e.g., tennis, club house, pools, cafe, long and short term hotel suites, theater, Cielito Lindo, a la carte assisted living services).
What makes this place so amazing is not only the beauty and sense of community, but also the fact that you can have the lifestyle you desire with the care that you need as those needs arise… and all of this at a cost of living that is less than half of what it would cost comparably in the US.
Learn more about Cielito Lindo here.
Download the Expatriate Guide for Senior Living in Mexico – For your convenience, the entire 50-page guide is available for download as a PDF. Send us an email us at information.cielitolindo@gmail.com or give us a call for any other information you might want
English speaking: 1.888.406.7990 (in US & CDN) 00.1.881.406.7990 (in MX)
Spanish speaking: 1.52.415.155.9547 (in US & CDN) 1.415.155.9547 (in MX)
We would love to hear from you and we are here to serve you with lots of helpful information, support, and zero-pressure sales.